PubMed

Decisions about treating community-acquired pneumonia.

Mandell L.

Ann Intern Med. 2005 Feb 1;142(3):215-6. No abstract available. PMID: 15684211 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Can patients with pneumonia take their antibiotics at home?

[No authors listed]

Ann Intern Med. 2005 Feb 1;142(3):I30. No abstract available. PMID: 15684200 [PubMed - indexed for MEDLINE]Related articlesFree article

Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.

Carratalà J, Fernández-Sabé N, Ortega L, Castellsagué X, Rosón B, Dorca J, Fernández-Agüera A, Verdaguer R, Martínez J, Manresa F, Gudiol F.

Ann Intern Med. 2005 Feb 1;142(3):165-72.PMID: 15684204 [PubMed - indexed for MEDLINE]Related articlesFree article

Monotherapy in severe community-acquired pneumonia: is it worthy?

Torres A.

Chest. 2005 Jul;128(1):10-3. No abstract available. PMID: 16002907 [PubMed - indexed for MEDLINE]Related articlesFree article

Performance measurement in community-acquired pneumonia: consequences intended and unintended.

File TM Jr, Gross PA.

Clin Infect Dis. 2007 Apr 1;44(7):942-4. Epub 2007 Feb 20. No abstract available. PMID: 17342645 [PubMed - indexed for MEDLINE]Related articles

The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

Gogol M.

Ann Intern Med. 2009 Feb 3;150(3):219; author reply 220. No abstract available. PMID: 19189914 [PubMed - indexed for MEDLINE]Related articlesFree article

The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

Srouji N.

Ann Intern Med. 2009 Feb 3;150(3):220; author reply 220. No abstract available. PMID: 19189917 [PubMed - indexed for MEDLINE]Related articlesFree article

The unintended, negative consequences of the door-to-antibiotic measure for pneumonia.

Dean NC.

Ann Intern Med. 2009 Feb 3;150(3):219; author reply 220. No abstract available. PMID: 19189915 [PubMed - indexed for MEDLINE]Related articlesFree article

[Treatment of community acquired pneumonia]

Böszörményi Nagy G.

Orv Hetil. 2004 May 30;145(22):1189-92. Review. Hungarian. No abstract available. PMID: 15279407 [PubMed - indexed for MEDLINE]Related articles

Community-acquired pneumonia: treatment at home or in the hospital?

Aujesky D, Fine MJ.

Am J Med. 2008 Dec;121(12):1038-40. No abstract available. PMID: 19028194 [PubMed - indexed for MEDLINE]Related articles

[Therapy of non-nosocomial pneumonia]

Drömann D, Schaaf B.

MMW Fortschr Med. 2008 Jan 24;150(3-4):31-4; quiz 35. Review. German. No abstract available. PMID: 18326476 [PubMed - indexed for MEDLINE]Related articles

Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.

Hammerschlag MR, Roblin PM.

Antimicrob Agents Chemother. 2000 May;44(5):1409. No abstract available. PMID: 10819727 [PubMed - indexed for MEDLINE]Related articlesFree article

A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial.

Samsa GP, Matchar DB, Harnett J, Wilson J.

Chest. 2005 Nov;128(5):3246-54.PMID: 16304269 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.

Curr Med Res Opin. 2008 Mar;24(3):895-906.PMID: 18419876 [PubMed - indexed for MEDLINE]Related articles

Community acquired pneumonia.

Loeb M.

Clin Evid. 2002 Dec;(8):1546-57. Review. No abstract available. Update in: Clin Evid. 2003 Dec;(10):1724-37. PMID: 12603953 [PubMed - indexed for MEDLINE]Related articles

Community acquired pneumonia.

Loeb M.

Clin Evid. 2002 Jun;(7):1358-68. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):1546-57. PMID: 12230751 [PubMed - indexed for MEDLINE]Related articles

Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.

Leroy O, Saux P, Bédos JP, Caulin E.

Chest. 2005 Jul;128(1):172-83.PMID: 16002932 [PubMed - indexed for MEDLINE]Related articlesFree article

What have we learned about how to measure quality of care for patients with community-acquired pneumonia?

Metersky ML, Abend SL, Meehan TP.

Respir Care Clin N Am. 2005 Mar;11(1):87-98. Review.PMID: 15763224 [PubMed - indexed for MEDLINE]Related articles

Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.

Shorr AF, Khashab MM, Xiang JX, Tennenberg AM, Kahn JB.

Respir Med. 2006 Dec;100(12):2129-36. Epub 2006 May 26.PMID: 16730170 [PubMed - indexed for MEDLINE]Related articles

Oral antibiotics for the treatment of severe pneumonia in children.

Klugman KP, Madhi SA.

Lancet. 2004 Sep 25-Oct 1;364(9440):1104-5. No abstract available. PMID: 15451204 [PubMed - indexed for MEDLINE]Related articles